Keywords: gw, get, 6m, milestone, almirall, strong, sativex
GW to get $11.6M milestone from Almirall on strong Sativex Ph III data
Article | 02 April 2009
Spanish drugmaker Laboratorios Almirall SA will pay the UK's GW Pharmaceuticals a milestone payment of GBP8.0 million ($11.6 million) after it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
